Earnings Date: August 4, 2026 Prepared: August 3, 2026 Reporting Period: Q2 2026 (April – June 2026)
Key Takeaway: The setup into Q2 is a modest beat — consensus is a manageable bar given KMB's strong innovation pipeline and volume/mix momentum, but the $50M bottom-line headwind from Middle East-driven input cost inflation and the California DC fire is the single biggest swing factor.
Heading into Q2 2026, the bar for Kimberly-Clark is achievable but not easy. Consensus organic sales growth of ~1.2% sits below the company's own full-year target of ~2.5%, reflecting two known headwinds management pre-disclosed on the Q1 call: a ~$20M top-line drag from the California distribution center fire (70–80 bps for North America) and the toughest prior-year comparable of the year (total enterprise +4%, North America volume +5% in Q2 2025). Management's tone on the Q1 call was constructive — they described Q2 as a temporary soft patch before a back-half acceleration — and the innovation pipeline entering Q2 was characterized as "one of the strongest in our history." Estimate revisions have been largely stable since the Q1 print, with adjusted EPS consensus ticking up slightly from $1.64 to $1.62 (post-Q1 baseline), suggesting the street has absorbed the known headwinds without panic. The stock has rallied ~11% since the Q1 earnings date (vs. XLP +2.4%, SPY +5.0%), pricing in a degree of execution confidence, which raises the bar for a positive surprise. The key wildcard is input cost trajectory: management flagged a potential $150–170M gross incremental cost headwind in H2 if oil stays near $100/bbl, and any update on whether that risk is materializing — or being mitigated — will drive the stock reaction more than the Q2 print itself.
Key Takeaway: Consensus sets a low bar on organic sales (~1.2%) given known headwinds, while adjusted EPS (~$1.62) is the bigger swing factor — the $50M pre-disclosed bottom-line hit from input costs and the DC fire is already in estimates, so any mitigation or upside on volume/mix could drive a beat.
KPI | Last Qtr Actual (Q1 2026) | Prior Year (Q2 2025) | Consensus Estimate (Q2 2026) | YoY Change | Guidance | Cons. vs. Guidance |
Net Sales ($B) | $4.163B | $4.163B | $4.224B | +1.5% YoY | No specific Q2 guidance | N/A |
Organic Sales Growth (%) | 2.5% | 3.9% | ~1.2% | -270 bps YoY | "Slightly below Q1" (~2%) | ~-80 bps below guidance midpoint |
Volume + Mix (%) | 3.0% | 5.0% | ~1.0% | -400 bps YoY | No specific Q2 guidance | N/A |
Adj. Operating Margin (%) | 17.6% | 17.1% | ~16.8% | -30 bps YoY | FY: +70–80 bps expansion | Below FY trajectory (Q2 soft patch) |
Adj. EPS – Excl. Disc. Ops ($) | $1.60 | $1.63 | $1.62 | -0.6% YoY | FY: double-digit growth (cont. ops) | In line with FY trajectory |
Source: Visible Alpha Consensus and Actuals Data. Net Sales, Organic Sales Growth, Volume + Mix, Operating Margin, and Adj. EPS sourced from Visible Alpha (https://insights.visiblealpha.com/mex/KMB/NMV/IS and /RI and /RV). Q2 2026 consensus as of August 3, 2026. Prior year actuals are reported figures.
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Organic Sales | 2.5% | 1.9% | +60 bps | Beat |
Q1 2026 | Adj. EPS (excl. disc. ops) | $1.60 | $1.54 | +3.9% | Beat |
Q4 2025 | Organic Sales | 2.1% | 2.1% | 0 bps | In Line |
Q4 2025 | Adj. EPS (excl. disc. ops) | $1.43 | $1.41 | +1.4% | Beat |
Q3 2025 | Organic Sales | 2.5% | 1.6% | +90 bps | Beat |
Q3 2025 | Adj. EPS (excl. disc. ops) | $1.45 | $1.40 | +3.6% | Beat |
Q2 2025 | Organic Sales | 3.9% | 1.5% | +240 bps | Beat |
Q2 2025 | Adj. EPS (excl. disc. ops) | $1.63 | N/A — not in VA for this period | N/A | N/A |
Q1 2025 | Organic Sales | -1.4% | 0.7% | -210 bps | Miss |
Q1 2025 | Adj. EPS (excl. disc. ops) | $1.62 | N/A — not in VA for this period | N/A | N/A |
Q4 2024 | Organic Sales | 2.5% | 2.1% | +40 bps | Beat |
Q4 2024 | Adj. EPS (excl. disc. ops) | $1.19 | N/A — not in VA for this period | N/A | N/A |
Q3 2024 | Organic Sales | 1.5% | 3.5% | -200 bps | Miss |
Q3 2024 | Adj. EPS (excl. disc. ops) | $1.56 | N/A — not in VA for this period | N/A | N/A |
Pattern: KMB has beaten organic sales consensus in 5 of the last 6 quarters where data is available, with the lone miss in Q1 2025 driven by a portfolio restructuring impact; the consistent pattern of setting a low bar and outperforming on volume/mix is a structural feature of management's guidance philosophy. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance is unchanged since the Q1 call — management reaffirmed the full-year framework but deliberately left the potential $150–170M H2 input cost headwind outside the outlook, creating a meaningful unresolved risk that the Q2 call must address.
The baseline for all guidance is the Q1 2026 earnings call (April 28, 2026). No post-earnings 8-K, investor day, or conference has revised the numerical guidance. The Deutsche Bank dbAccess Global Consumer Conference (June 4, 2026) was attended by CEO Mike Hsu and CFO Nelson Urdaneta but was used to elaborate on the Kenvue acquisition thesis rather than update financial guidance. The departure of Principal Accounting Officer Andrew Scribner (effective May 22, 2026) was disclosed via 8-K on May 5, 2026; CFO Urdaneta assumed the interim PAO role with no guidance change.
Metric | Initial Guidance (Q1 2026 Call, Apr 28) | Revised Guidance | Current Consensus | Note |
FY Organic Sales Growth | In line to ahead of ~2.5% category growth | — | ~2.5% (FY) | Unchanged; no post-earnings update |
FY Adj. Operating Profit Growth | Mid-to-high single-digit growth (constant currency) | — | ~$2.92B (FY) | Unchanged; consensus tracking guidance |
FY Adj. EPS (Continuing Ops) | Double-digit growth (constant currency) | — | ~$6.76 (FY) | Unchanged; consensus implies ~9% growth |
FY Gross/Op. Margin Expansion | +70–80 bps (both gross and operating margin) | — | ~17.4% op. margin (FY) | Unchanged; Q2 expected to be soft patch before H2 pickup |
Q2 Organic Sales | "Slightly below Q1" (~2%); $20M DC fire headwind | — | ~1.2% | Consensus below guidance midpoint; DC fire + tough comp fully absorbed |
Q2 Bottom-Line Impact | ~$50M headwind (Middle East inflation + DC fire); expected to recover in H2 | — | Reflected in ~$1.62 EPS est. | Unchanged; key question is whether H2 recovery is still on track |
H2 Input Cost Risk (Unguided) | $150–170M gross incremental cost if oil ~$100/bbl; NOT in guidance | — | Not in consensus | Biggest unresolved risk; Q2 call must address mitigation progress |
Key Takeaway: Estimates have been remarkably stable since the Q1 print — organic sales consensus ticked down slightly (reflecting the DC fire and tough comp), while EPS estimates are essentially flat, suggesting the street has fully priced in the known Q2 headwinds and is waiting for the H2 input cost update.
KPI (Period) | Estimate ~5 Days Post Q1 (May 5, 2026) | Current Consensus (Aug 3, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Cons. vs. Guidance (%) |
Organic Sales — Q2 2026 | ~1.8% | ~1.2% | -60 bps | "Slightly below Q1" (~2%) | Unchanged | — | ~-80 bps below guidance |
Net Sales — Q2 2026 | $4.248B | $4.224B | -0.6% | No specific Q2 guidance | Unchanged | — | N/A |
Adj. EPS (excl. disc. ops) — Q2 2026 | $1.640 | $1.619 | -1.3% | No specific Q2 guidance | Unchanged | — | N/A |
Organic Sales — FY 2026 | ~2.6% | ~2.5% | -10 bps | In line to ahead of ~2.5% category | Unchanged | — | At guidance midpoint |
Net Sales — FY 2026 | $16.888B | $16.857B | -0.2% | No specific FY $ guidance | Unchanged | — | N/A |
Adj. EPS (excl. disc. ops) — FY 2026 | $6.829 | $6.757 | -1.1% | Double-digit growth (cont. ops, cc) | Unchanged | — | ~9% growth; slightly below "double-digit" guidance |
Source: Visible Alpha Consensus and Actuals Data (https://insights.visiblealpha.com/mex/KMB/NMV/IS and /RI). May 5, 2026 as-of date represents ~5 trading days post Q1 2026 earnings (April 28, 2026). The modest downward drift in Q2 estimates reflects absorption of the DC fire headwind and tough comp, while FY estimates are essentially flat — consistent with management's reaffirmed guidance and the market's view that H2 will recover.
Key Takeaway: KMB has significantly outperformed both XLP (+2.4%) and the S&P 500 (+5.0%) since the Q1 earnings date, rallying ~11% through July 31, 2026 — driven by multiple re-rating (P/E expanded from ~13x to ~14.6x NTM) as the Kenvue acquisition thesis gained credibility, not by estimate revisions (which were flat). The stock's outperformance raises the bar for a positive reaction on Q2 results.
KMB vs. XLP (Consumer Staples ETF) vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings Date (April 28, 2026). KMB +11.0% through July 31, 2026; XLP +2.4%; SPY +5.0%. Source: Yahoo Finance / Stock Price Data.
Key events since Q1 earnings (April 28, 2026):
Performance decomposition: Over the 3-month window, KMB's NTM P/E expanded from ~13.0x to ~14.6x (+12%), while NTM EV/EBITDA moved from ~10.4x to ~11.3x (+9%). The stock's outperformance is almost entirely multiple-driven, not earnings-revision-driven — a pattern that is more fragile and more sensitive to any guidance disappointment on the Q2 call. Source: Stock Price Data (Yahoo Finance); Valuation multiples from Implied platform.
Key Takeaway: The most important development since Q1 earnings is the Deutsche Bank conference (June 4) where management escalated conviction on the Kenvue acquisition — describing specific revenue synergy opportunities and confirming integration is tracking ahead of plan. The unresolved H2 input cost risk ($150–170M if oil stays ~$100/bbl) remains the key overhang for the print.
Key Takeaway: No open-market buys; all transactions are discretionary sales by departing or active insiders in the days immediately following Q1 earnings. The sales are not alarming in isolation — Scribner's sale is consistent with his departure, and Chen's sales are modest relative to her remaining position — but the absence of any insider buying despite the stock trading near multi-year lows at the time of the Q1 print is a mild negative signal.
Name | Title | Transaction Type | Shares | Date | Note |
Andrew Scribner | Controller, VP & FP&A (departing) | Open Market Sale | 4,095 shares | May 6, 2026 | Discretionary sale; consistent with departure (effective May 22, 2026). Sold entire remaining position (0 shares post-transaction). |
Katy Chen | President, International Personal Care | Open Market Sale | 1,596 shares | May 4, 2026 | Discretionary sale; 8,362 shares remaining post-transaction. Not flagged as 10b5-1 plan. |
Katy Chen | President, International Personal Care | Open Market Sale | 1,405 shares | Apr 30, 2026 | Discretionary sale; 6,502 shares remaining post-transaction. Executed 2 days after Q1 earnings beat. |
Source: SEC Form 4 Filings (Insider Transaction Data). Form 4 filing dates: Scribner — May 6, 2026 (https://www.sec.gov/Archives/edgar/data/55785/000122520826004974/xslF345X06/doc4.xml); Chen May 4 — May 4, 2026 (https://www.sec.gov/Archives/edgar/data/55785/000122520826004903/xslF345X06/doc4.xml); Chen Apr 30 — May 1, 2026 (https://www.sec.gov/Archives/edgar/data/55785/000122520826004749/xslF345X06/doc4.xml). Only open-market transactions (Form 4 codes P/S) included.
Key Takeaway: Peer commentary from Colgate-Palmolive (CL, Q2 2026 earnings July 31) and Church & Dwight (CHD, Q2 2026 earnings July 31) — both reporting their April–June 2026 quarters — provides a mixed but broadly constructive read-through for KMB's Q2 2026 print. Consumer spending remained resilient, category growth held near 2%, and promotional intensity was elevated but manageable. The key shared headwind is Middle East-driven input cost inflation (~$30M for CHD, peaking in H2 for CL), which directly validates KMB's pre-disclosed $50M Q2 bottom-line headwind. Procter & Gamble (PG, reporting its fiscal Q4 2026 on July 29) offered a cautious read on the US consumer and soft guidance, which is a mild negative read-through for KMB's North America segment.
Filter applied: Only commentary from peers' Q2 2026 earnings calls (July 29–31, 2026) that directly describes conditions during the April–June 2026 calendar quarter — which is KMB's current reporting period — is included below. Forward-looking guidance from peers about their own Q3 2026 (July–September) and retrospective commentary about prior peer quarters are excluded.
Relevance: CL's Q2 2026 covers April–June 2026, the same calendar quarter as KMB's Q2 2026. CL competes directly with KMB in oral care, personal care, and household products globally.
Source: Colgate-Palmolive Q2 2026 Earnings Call Transcript (July 31, 2026), documents/CL/transcript/earnings/2026Q2/raw_document.txt.
Relevance: CHD's Q2 2026 covers April–June 2026, the same calendar quarter as KMB's Q2 2026. CHD competes in household and personal care categories and is a useful read-through for US consumer demand and category dynamics.
Source: Church & Dwight Q2 2026 Earnings Call Transcript (July 31, 2026), documents/CHD/transcript/earnings/2026Q2/raw_document.txt.
Relevance: PG's fiscal Q4 2026 covers April–June 2026, the same calendar quarter as KMB's Q2 2026. PG is KMB's most direct competitor in diapers (Pampers vs. Huggies), tissue, and personal care globally.
Source: Procter & Gamble Fiscal Q4 2026 Earnings (July 29, 2026); public news sources (Barron's, WSJ) dated July 29, 2026.
Peer | Reporting Period | Key Read-Through for KMB Q2 2026 | Signal |
Colgate-Palmolive (CL) | Q2 2026 (Apr–Jun) | US category softness in May (gasoline prices, consumer uncertainty); recovery in June but below historical levels; heightened competitive activity; retailer inventory reductions; input costs peaking in H2 | Mixed |
Church & Dwight (CHD) | Q2 2026 (Apr–Jun) | Consumer spending resilient; category growth 2.7% (above 2% expectation); $30M Middle East input cost headwind (validates KMB's $50M); retail inventory movements immaterial; elevated promotional activity in laundry | Broadly Positive |
Procter & Gamble (PG) | Fiscal Q4 2026 (Apr–Jun) | Sales miss; soft FY guidance; inflation-squeezed US consumer; harder to sell core brands; cautious H2 outlook | Mild Negative |